Form 10-Q Dicerna Pharmaceuticals For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Dicerna Pharma (DRNA) Misses Q1 EPS by 6c
May 11, 2015 4:40 PM EDTDicerna Pharma (NASDAQ: DRNA) reported Q1 EPS of ($0.79), $0.06 worse than the analyst estimate of ($0.73).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
... More